Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This study evaluates the effectiveness of robotic biopsies in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.
Eligibility criteria
Qualifiers
Subject age 18 years and older
Subject is scheduled/was scheduled for a bronchoscopy as part of standard of care
Subject with a moderate to high risk of lung cancer based on clinical demographic and radiologic information or with suspected metastatic disease
Ability to provide blood or saliva sample
Disqualifiers
Individuals who have situations that would limit compliance with the study requirements
Institutionalized (i.e. federal medical prison)
Pregnant
Prior germline genetic testing with a 40+ multi-gene panel within the last 1 year of enrollment
Trial design
Treatments tested in this trial
- Non-Interventional Study
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov